New research shows that spine disease, once considered a rarity in chronic recurrent multifocal osteomyelitis, affects as many as 10-35 per cent of patients and is asymptomatic in one-third.
Washington [US], July 12 (ANI): According to a new study, pregnant women with the eating disorder anorexia nervosa run five times the risk to give birth to underweight babies.
Washington [US], July 9 (ANI): A recent study found that pregnant women with the eating condition anorexia nervosa are five times more likely to give birth to babies who are underweight.
Washington [US], January 20 (ANI): A team of researchers has developed a successful intervention combining education and workflow that increased primary care screenings for geriatric conditions like falls and dementia.
Washington [US], October 28 (ANI): A team of researchers have discovered a promising way to reduce knee replacement patients' risk of opioid addiction: Participate in physical therapy either before or after total knee replacement surgery.
Washington [US], October 28 (ANI): A team of researchers have discovered a promising way to reduce knee replacement patients' risk of opioid addiction: Participate in physical therapy either before or after total knee replacement surgery.
4baseCare a precision oncology company in India launched their product - TARGT Indiegene Indias largest and first population-specific tumour gene panel derived from Whole Exome and Whole Transcriptome data of over 1500 cancer patients across 28 different cancer typesFor example the TARGT Indiegene cancer panel is based on insights generated from tumour tissues of Indian cancer patients resulting in better success rates using precision medicine in the management of cancerThe insights from research have helped build the largest resource of mutational signatures identified in cancer patients in IndiaSupporting the research and commercialisation initiative are Illumina Accelerator Mount Judi Ventures growX Ventures Season Two Ventures First In Ventures and a few strategic angel investorsAbout 4baseCare4baseCare an Illumina Accelerator Company is engaged in the development of cutting-edge precision oncology solutions using advanced genomics and next-gen digital health technology to personalise patient care in oncology
\
\
\
\
\
\
\
\
\
\
\
\
\
\
